CD | UC | HC | |
---|---|---|---|
(n = 173) | (n = 105) | (n = 188) | |
Gender (%female) | 50,86 | 53,33 | 53,15 |
Age (yr) | |||
Mean | 38,4+/−12,2 | 44,9+/−12,9 | 40,0+/−12,94 |
Range | 16–77 | 21–69 | 19–61 |
ND | 16,5 % | 8 % | |
Drugs (%) | |||
Azathioprine | 43,35 | 15,20 | - |
Budenoside | 3,47 | 4,80 | - |
Infliximab | 15,60 | 2,90 | - |
Mesasalazine | 57,23 | 63,80 | - |
Metronidazol | 4,62 | 2,90 | - |
Prednisolone | 8,67 | 11,40 | - |
Disease Location (%) | |||
Rectum (E1) | - | 41,90 | - |
Left colon (E2) | - | 17,10 | - |
Colon (E3, L2) | 12,70 | 31,40 | - |
Ileum (L1) | 42,2 | - | - |
Ileocolon (L3) | 30,60 | - | - |
Upper digestive tract (L4) | 2,90 | - | - |
ND | 11,60 | 9,50 | - |
Active Disease (%) | 16,18 | 14,28 | - |